VDAC3 and neuroblastoma: Commercially available pharmacological inhibitors of SDHA (malonate), HSP90AB1 (geldanamycin), and VDAC3 (TRO19622) were used for functional evaluation of the TDP-43 genetic-interacting loci in N2a neuroblastoma cells.